Gemcitabina en 4 pacientes con colangiocarcinoma / Gemcitabine in the treatment of cholangiocarcinoma: report of 4 cases
Rev. méd. Chile
;
129(8): 911-916, ago. 2001. ilus, tab
Article
in Spanish
| LILACS
| ID: lil-300152
ABSTRACT
Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Bile Duct Neoplasms
/
Cholangiocarcinoma
/
Deoxycytidine
/
Antineoplastic Agents
Limits:
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2001
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Universidad de Chile/CL
Similar
MEDLINE
...
LILACS
LIS